Cancer Immunotherapy MSc 12 months Postgraduate Programme By London Metropolitan University |TopUniversities
Programme Duration

12 monthsProgramme duration

Tuitionfee

20,000 GBPTuition Fee/year

Application Deadline

23 Nov, 2026Application Deadline

Starting Month

Jan, SepStarting Month

Programme overview

Main Subject

Immunology

Degree

MSc

Study Level

Master's

Study Mode

On Campus

Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.


The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.


We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.


You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.


The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Programme overview

Main Subject

Immunology

Degree

MSc

Study Level

Master's

Study Mode

On Campus

Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.


The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.


We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.


You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.


The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Admission Requirements

70+
4.5+
2.7+
6+
You will be required to have:

at least a lower second (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis)

23 Nov 2026
1 Year
Jan
Sep

Tuition fees

Domestic
11,000 GBP
International
20,000 GBP

Scholarships

Selecting the right scholarship can be a daunting process. With countless options available, students often find themselves overwhelmed and confused. The decision can be especially stressful for those facing financial constraints or pursuing specific academic or career goals.

To help students navigate this challenging process, we recommend the following articles:

More programmes from the university

Postgrad Programmes 358

About QS TopUniversities.com

TopUniversities.com is QS's trusted student decision platform, built on QS's globally recognised higher education expertise. It brings together the QS World University Rankings, the QS World University Rankings by Subject, trusted university insights and data, information provided by universities, career insights, scholarships, QS Events and QS TopUniversities Apply to help prospective students make higher education decisions with confidence.

QS Career Match is a part of QS TopUniversities.com, helping students connect their career ambitions with the subjects and universities that can help them get there.